BioSpace News Archive

Sofinnova Crossover I SLP converted into ordinary shares of the Company all of the 7,500,000 convertible bonds (“CBs”) it had subscribed for in June 2019

Indivior PLC announced that its full year 2019 press release is now available via the London Stock Exchange’s Regulatory News Service and on the “Investors” section of the company’s website at www.indivior.com.

Continued progress with proprietary and wholly owned candidate drug MIV-818 for liver cancer

The Delta Dental Institute published a white paper examining the state of health literacy in America and its impact on oral and overall health outcomes.

Reimbursement Pathway Established for MolecuLight’s i:X Procedure in Wound Care

Co-Diagnostics, Inc. (Nasdaq: CODX), announced today that it has been invited to be a featured speaker to present its rapid response to the new coronavirus (Covid-19) global health concern, as well as its multiplex PCR solutions for mosquito-borne diseases, at the 3rd International Conference on Zika Virus and Aedes Related Infections.

Canadians from coast to coast to coast will wear red in observation of Wear Red Canada, a national awareness campaign initiated by the Canadian Women’s Heart Health Alliance to bring attention to women’s cardiovascular health issues.

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the appointment of Amber Salzman, Ph.D., to the Company’s Board of Directors, expanding the board to 11 members.

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the acquisition of Digital Surgery, a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training

Seqster, the award-winning SaaS-based technology platform enabling person-centric health data management, today announced that the company has secured investment from Takeda Pharmaceuticals, a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan.